Align Technology, Inc. (NASDAQ:ALGN) Shares Sold by First Quadrant L P CA

First Quadrant L P CA decreased its stake in Align Technology, Inc. (NASDAQ:ALGN) by 14.0% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 19,000 shares of the medical equipment provider’s stock after selling 3,100 shares during the period. First Quadrant L P CA’s holdings in Align Technology were worth $2,852,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. Intellectus Partners LLC boosted its position in Align Technology by 1.2% in the first quarter. Intellectus Partners LLC now owns 3,498 shares of the medical equipment provider’s stock valued at $401,000 after buying an additional 41 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its position in Align Technology by 2.8% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 1,917 shares of the medical equipment provider’s stock valued at $206,000 after buying an additional 52 shares in the last quarter. Van ECK Associates Corp boosted its position in Align Technology by 6.9% in the first quarter. Van ECK Associates Corp now owns 1,057 shares of the medical equipment provider’s stock valued at $121,000 after buying an additional 68 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its position in Align Technology by 0.4% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 17,763 shares of the medical equipment provider’s stock valued at $2,038,000 after buying an additional 77 shares in the last quarter. Finally, Northwestern Mutual Investment Management Company LLC boosted its position in Align Technology by 0.7% in the first quarter. Northwestern Mutual Investment Management Company LLC now owns 13,004 shares of the medical equipment provider’s stock valued at $1,492,000 after buying an additional 94 shares in the last quarter. 88.07% of the stock is currently owned by hedge funds and other institutional investors.

Align Technology, Inc. (NASDAQ ALGN) traded down 0.44% on Friday, reaching $168.61. 1,393,519 shares of the company were exchanged. The firm has a market capitalization of $13.51 billion, a P/E ratio of 57.74 and a beta of 1.55. The firm has a 50-day moving average of $162.73 and a 200 day moving average of $132.63. Align Technology, Inc. has a 12-month low of $83.27 and a 12-month high of $179.76.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $0.85 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.73 by $0.12. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The business had revenue of $356.50 million for the quarter, compared to the consensus estimate of $343.43 million. During the same period last year, the firm earned $0.62 earnings per share. The company’s quarterly revenue was up 32.3% on a year-over-year basis. On average, equities analysts predict that Align Technology, Inc. will post $3.40 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by BNB Daily and is the property of of BNB Daily. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/first-quadrant-l-p-ca-sells-3100-shares-of-align-technology-inc-nasdaqalgn-updated-updated-updated.html.

Several research firms have commented on ALGN. Morgan Stanley reissued an “overweight” rating and set a $182.00 target price (up previously from $175.00) on shares of Align Technology in a research report on Monday, July 17th. Credit Suisse Group restated an “outperform” rating and set a $170.00 price target (up previously from $140.00) on shares of Align Technology in a research note on Thursday, July 13th. Stifel Nicolaus restated a “buy” rating and set a $205.00 price target (up previously from $200.00) on shares of Align Technology in a research note on Monday, August 7th. Leerink Swann restated an “outperform” rating and set a $149.00 price target (up previously from $118.00) on shares of Align Technology in a research note on Saturday, April 29th. Finally, Jefferies Group LLC restated a “buy” rating and set a $150.00 price target (up previously from $110.00) on shares of Align Technology in a research note on Saturday, April 29th. Ten research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of “Buy” and a consensus price target of $174.40.

In other news, VP Sreelakshmi Kolli sold 1,000 shares of the stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $144.00, for a total value of $144,000.00. Following the completion of the sale, the vice president now directly owns 23,785 shares of the company’s stock, valued at $3,425,040. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Joseph Lacob sold 50,000 shares of the stock in a transaction on Wednesday, May 31st. The stock was sold at an average price of $144.98, for a total transaction of $7,249,000.00. The disclosure for this sale can be found here. Insiders sold 54,874 shares of company stock worth $7,950,701 over the last quarter. Insiders own 2.00% of the company’s stock.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply